Effective aminoglycoside antibiotic for multidrug-resistant bacteria
US-2020155582-A1 · May 21, 2020 · US
Aminoglycoside antibiotics
US9260465B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9260465-B2 |
| Application number | US-201313970841-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 20, 2013 |
| Priority date | Jun 2, 2006 |
| Publication date | Feb 16, 2016 |
| Grant date | Feb 16, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention relates to novel aminoglycoside antibiotics, which have potent antimicrobial activity against bacteria, which induce infectious diseases, particularly MRSA, and has no significant nephrotoxicity, and process for producing them. More particularly, the present invention relates to compounds represented by formula (Ia) or their pharmacologically acceptable salts or solvates, or their diastereomer mixtures, antimicrobial agents comprising them, and a process for producing them.
First claim
Opening claim text (preview).
The invention claimed is: 1. A process for producing a compound represented by formula (Ia): wherein R 5ax and R 5eq , which are different from each other, represent a hydrogen atom or hydroxyl, and R 4″ax and R 4″eq , which are different from each other, represent a hydrogen atom or hydroxyl, n is an integer of 1 to 4, and the steric configuration of carbon atom atta…
Assignees
Inventors
Classifications
- C07H15/234Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
- C07H15/224Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9260465B2 cover?
- This invention relates to novel aminoglycoside antibiotics, which have potent antimicrobial activity against bacteria, which induce infectious diseases, particularly MRSA, and has no significant nephrotoxicity, and process for producing them. More particularly, the present invention relates to compounds represented by formula (Ia) or their pharmacologically acceptable salts or solvates, or thei…
- Who is the assignee on this patent?
- Meiji Seika Pharma Co Ltd, Microbial Chem Res Found
- What technology area does this patent fall under?
- Primary CPC classification C07H15/234. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).